Prominent Canadian researcher in Denmark: Why I left a top job in California
NMD Pharma Initiates a Combined Phase I/IIa Clinical Trial of NMD670 for the Treatment of Symptoms of Myasthenia Gravis
NMD Pharma - PIR International
NMD Pharma company information, funding & investors | Dealroom.co
NMD Pharma, finalist i Life Sciences kategorien - EY Danmark
NMD Pharma
Management — NMD Pharma
NMD Pharma is Strengthening Muscles in Neuromuscular Disorders
Labiotech.eu on Twitter: "NMD Pharma, from @AarhusUni, is willing to tackle Neuromuscular Transmission Disorders #BioEquity2016… "
Investors — NMD Pharma
NMD Pharma
NMD Pharma Information | NMD Pharma Profile
Klaus Wilhardt - Corporate identity, Design, Logo/navnetræk og designguides
NMD Pharma | The Org
NMD Pharma
Neuromuscular Drug Development Summit (NMD) - Pharma Journalist
NMD Pharma Receives Approval to Start a combined Phase I/IIa Clinical Trial of NMD670 for the Treatment of Symptoms of Myasthenia Gravis
NMD Pharma company information, funding & investors | Dealroom.co
Company Presentation
Erhverv Aarhus - 照片| Facebook
Management — NMD Pharma
NMD Pharma - Inkef capital
NMD Pharma A/S | LinkedIn
Nete Huus's email & phone | NMD Pharma ApS's Senior Scientist email
